Lazard Capital Initiates Coverage on McKesson (MCK) with a Buy
More News related to MCK
- Manson Creek Resources Negotiates Acquisition of Virgin Arm Gold Project
- Manson Creek Secures Ownership of Meridian Gold Project
- McKesson Board Turns Blind Eye to Shareholders
- McKesson Declares Quarterly Dividend October 30, 2009
- Auriga Reiterates a 'Buy' Rating on McKesson Corp (MCK); Raises Estimates & PT
More News related to New Coverage
- HSBC Starts PWRD at Overweight, SNDA, NTES at Neutral
- Macquarie Initiates Coverage on Deere & Co (DE) with a Neutral
- MKM Partners Initiates Coverage on Hertz Global (HTZ) & Avis Budget Group (CAR)
- Jefferies & Co Initiates Coverage on Mettler-Toledo (MTD) with a Buy
- Jefferies & Co Initiates Coverage on Millipore (MIL) with a Buy
Lazard Capital initiates coverage on McKesson (NYSE: MCK) with a Buy. Price target $55.
To see more analyst ratings on MCK Click Here.
McKesson Corporation (McKesson) provides supply, information and care management products and services across the healthcare industry.
Related Categories
New CoverageStocks Mentioned
+0.61Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
